Corrigendum: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma

Pedro A. Pérez-Mancera,Alistair G. Rust,Louise van der Weyden,Glen Kristiansen,Allen Li,Aaron L. Sarver,Kevin A. T. Silverstein,Robert Grützmann,Daniela Aust,Petra Rümmele,Thomas Knösel,Colin Herd,Derek L. Stemple,Ross Kettleborough,Jacqueline A. Brosnan,Ang Li,Richard A. Morgan,Spencer Knight,Jun Yu,Shane Stegeman,Lara S. Collier,Jelle ten Hoeve,Jeroen de Ridder,Alison P. Klein,Michael Goggins,Ralph H. Hruban,David K. Chang,Andrew V. Biankin,Sean M. Grimmond,Lodewyk F. A. Wessels,Stephen A. Wood,Christine A. Iacobuzio-Donahue,Christian Pilarsky,David A. Largaespada,David J. Adams,David A. Tuveson

Corrigendum: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma

2013

Nature 486, 266–270 (2012); doi:10.1038/nature11114 In this Letter, several authors from the Australian Pancreatic Cancer Genome Initiative were inadvertently omitted: Christopher J. Scarlett and Warren Kaplan from the The Kinghorn Cancer Centre; and Aldo Scarpa from the ARC-NET Center for Applied Research on Cancer.

Keywords:

Genomics
Cancer
USP9X
Cancer research
Adenocarcinoma
Biology
Deubiquitinating enzyme
pancreatic ductal adenocarcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations